The Role of Vitamin E Incorporated Oat Supplementation in Metabolic Syndrome (MetS) Patients
Metabolic Syndrome
About this trial
This is an interventional supportive care trial for Metabolic Syndrome
Eligibility Criteria
Inclusion Criteria: Age 18 years old and above Individuals who have been identified as having metabolic syndrome (meet ≥3 out of 5 NCEP-ATP III Criteria) Stable weight (± 2 kg during the past 3months) to ensure reliable weight changes with the treatment given. Not taking antioxidant/anti-inflammatory supplements (Example of antioxidant: vitamin C, vitamin E, grape seed extract, garlic capsule, ginkgo biloba); (Example of the anti-inflammatory supplement: fish oil, curcumin extract, ginger extract, spirulina) Exclusion Criteria: Having liver (chronic liver failure, cirrhosis, all types of hepatitis), kidney (chronic kidney disease, haemodialysis) or haematological (anaemia, thalassemia, haemophilia) disorders Cancer (all types) and endocrine disorders (Cushing's disease, gigantism and hyperthyroidism). Alcohol and drug abuse (self-mentioned or as recorded in the medical card) Hormone replacement therapy (for at least three months prior to entering the study) Use of steroids, chemotherapy, immunosuppressant, or radiotherapy Currently pregnant or lactating Participations currently under another supplementary program
Sites / Locations
- Advanced Medical and Dental Institute (AMDI)Recruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Placebo Comparator
No Intervention
Vitamin E incorporated oat
Placebo
Control
Oral vitamin E incorporated oat supplementation
Oral oat supplementation
Control